Delivery Order SPE2DR25D9112-SPE2DR26FDES8

The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 9, 2026, with a ceiling value of $18,516.41 for supply of JAKAFI 5 mg tablets (60 count) under its Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) indefinite delivery contract. DMS Pharmaceutical Group Inc. is a woman-owned small business. Place of performance is Park Ridge, IL. The order is firm fixed price with an ultimate completion date of February 10, 2026. PPV-G GEN V...

The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 17, 2026, for $19,246.77 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for supply of JAKAFI 10 mg tablets (60-count units). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group Inc. is a woman-owned small business. Place of...

The Defense Logistics Agency issued a $50,883.68 delivery order to DMS Pharmaceutical Group Inc. on February 6, 2026, for JAKAFI 5 mg tablets (60-count units) under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a DLA-administered indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support Department of Defense...

The Defense Logistics Agency issued a firm fixed-price delivery order valued at $12,364.81 to DMS Pharmaceutical Group Inc. for the supply of JAKAFI 10 mg tablets (60-count units). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was awarded this delivery order on December 30, 2025, with an ultimate completion date of December 31, 2025. The award carried no set-aside designation, demonstrating the contractor's...

The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 25, 2026, for $12,663.27, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) parent contract for supply of JAKAFI 10 mg tablets (60-count units). PPV-G GEN V is a Defense Logistics Agency initiative authorizing firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support...

The Defense Logistics Agency issued a $50,883.68 delivery order to DMS Pharmaceutical Group Inc. on February 23, 2026, for supply of Jakafi 5 mg tablets (60-count) under firm fixed-price terms. DMS Pharmaceutical Group Inc. is a woman-owned small business. The delivery order is issued under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a single-award indefinite delivery contract with a $499,999,999 ceiling. Place of performance is Park...

The Defense Logistics Agency awarded a delivery order valued at $24,793.16 to DMS Pharmaceutical Group Inc. for JAKAFI 5 mg tablets (60-count units) on November 20, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform work at its Park Ridge facility. This delivery order was issued under a firm fixed-price contract structure with no set-aside designation, allowing the vendor to compete on an unrestricted...

The Defense Logistics Agency awarded a $37,989.81 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of JAKAFI 10 mg tablets (60-count units). The award, issued on January 30, 2026, with an ultimate completion date of February 2, 2026, was made without set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. This...

The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 10, 2026, with a ceiling value of $55,678.45, for supply of JAKAFI 10 mg tablets (60-count units) under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products, branded and generic prescription drugs, over-the-counter medications,...

The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $24,793.16 to DMS Pharmaceutical Group Inc. for 60 tablets of JAKAFI 5 mg, with an ultimate completion date of December 12, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating its competitive capability in unrestricted federal procurement. The delivery order was issued under...